Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.79 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.71 |
| ▸ | LDHB | P07195 | 4/20 | 0.37 |
| ▸ | TERF2IP | Q9NYB0 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 2/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31087460 | 0.97 | KDM1A (0.84) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| Sulfuric Acid SCHEMBL28198732 | 0.94 | KDM1A (0.76) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL15873843 | 0.94 | KDM1A (0.77) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL2476060 | 0.94 | KDM1A (0.77) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL135811 | 0.94 | KDM1A (0.77) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL28176727 | 0.91 | KDM1A (0.66) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL28868015 | 0.91 | KDM1A (0.83) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| Sulfuric Acid SCHEMBL11906224 | 0.90 | KDM1A (0.95) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| Sulfuric Acid SCHEMBL14637227 | 0.90 | KDM1A (0.95) | KDM1ARCOR1LDHBTERF2IPKEAP1 | |
| SCHEMBL16281102 | 0.90 | KDM1A (0.83) | KDM1ARCOR1LDHBTERF2IPKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4315 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739326-A2 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR Biome ApS (DK) | 2026-05-13 | — | — | EP | claimed |
| US-20260115234-A1 | PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA | SNIPR BIOME APS (DK) | 2026-04-30 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260041610-A1 | DRUG POWDERIZATION WITHIN VIALS | CMPD LICENSING, LLC (US) | 2026-02-12 | — | — | US | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| US-20260000678-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING, OR TREATING SYMPTOM ASSOCIATED WITH PSEUDO-ALLERGIC REACTION | TAKASAKI UNIV OF HEALTH AND WELFARE (JP) | 2026-01-01 | — | — | US | claimed |
| US-12447113-B2 | Drug powderization within vials | CMPD LICENSING, LLC (US) | 2025-10-21 | — | — | US | claimed |
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-20030157638-A1 | Novel beta-defensins | ADLER DAVID A (US) | 2003-08-21 | — | — | US | claimed |
| US-20030143259-A1 | For therapy of infections of the eye and surrounding tissues | SUN PHARMACEUTICAL INDUSTRIES, INC | 2003-07-31 | — | — | US | claimed |
| US-6569443-B1 | Applying an azalide antibiotic such as azithromycin in suspensin sustained release | INSITE VISION, INC. | 2003-05-27 | — | — | US | claimed |
| JP-2002540147-A | — | — | 2002-11-26 | — | — | JP | claimed |
| EP-1165058-A2 | USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS | INSITE VISION INCORPORATED (US) | 2002-01-02 | — | — | EP | claimed |
| EP-0744938-B1 | LIQUID OPHTHALMIC SUSTAINED RELEASE DELIVERY SYSTEM | NOVARTIS AG (CH) | 2001-09-05 | — | — | EP | claimed |
| WO-2000057866-A2 | USE OF AZALIDE ANTIBIOTICS FOR THE TOPICAL TREATMENT OR PREVENTION OF OCULAR INFECTIONS | INSITE VISION INCORPORATED (US) | 2000-10-05 | — | — | WO | claimed |
| EP-0744938-A1 | LIQUID OPHTHALMIC SUSTAINED RELEASE DELIVERY SYSTEM | Novartis AG (CH) | 1996-12-04 | — | — | EP | claimed |
| WO-1995022315-A1 | LIQUID OPHTHALMIC SUSTAINED RELEASE DELIVERY SYSTEM | CIBA-GEIGY AG (CH) | 1995-08-24 | — | — | WO | claimed |
| US-5422116-A | Administering to eye homogeneous liquid aqueous composition containing chitosan as release rate controlling agent | CIBA-GEIGY CORPORATION (US) | 1995-06-06 | — | — | US | claimed |